{"id":12144,"date":"2025-04-01T09:46:23","date_gmt":"2025-04-01T07:46:23","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12144"},"modified":"2026-03-03T10:29:38","modified_gmt":"2026-03-03T09:29:38","slug":"medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/","title":{"rendered":"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\"><strong>\u00c0 partir d\u2019aujourd\u2019hui, Interpharma, l\u2019association des entreprises pharmaceutiques suisses pratiquant la recherche, compte un nouveau membre en pointe dans le domaine de la recherche: Daiichi Sankyo. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale annuelle, le comit\u00e9 directeur a \u00e9t\u00e9 compl\u00e9t\u00e9 par des personnalit\u00e9s responsables \u00e0 l\u2019\u00e9chelon suisse et europ\u00e9en. En outre, le rapport annuel 2024 a \u00e9t\u00e9 pr\u00e9sent\u00e9. Celui-ci montre la contribution consid\u00e9rable de la branche pharmaceutique pour les patient-e-s, la recherche et le d\u00e9veloppement, ainsi que la prosp\u00e9rit\u00e9 de la Suisse.<\/strong><strong><\/strong><\/p>\n\n\n\n<p>Aujourd\u2019hui 1<sup>er<\/sup>&nbsp;avril 2025, l\u2019association de branche Interpharma accueille en tant que nouveau membre Daiichi Sankyo, une entreprise pharmaceutique pratiquant la recherche d\u2019importance internationale. Daiichi Sankyo d\u00e9veloppe des m\u00e9dicaments innovants pour am\u00e9liorer la sant\u00e9 et la qualit\u00e9 de vie. Les activit\u00e9s de recherche europ\u00e9ennes font partie de la strat\u00e9gie R&amp;D mondiale qui vise en particulier \u00e0 combler des lacunes th\u00e9rapeutiques dans le domaine des maladies cardio-vasculaires, des maladies du m\u00e9tabolisme ainsi que du cancer. Daiichi Sankyo (Schweiz) AG se concentre sur la distribution de m\u00e9dicaments cardio-vasculaires et oncologiques.<\/p>\n\n\n\n<p>Giuseppe Grossi, directeur g\u00e9n\u00e9ral de Daiichi Sankyo Schweiz, d\u00e9clare: \u00abNous sommes heureux de devenir membres d\u2019Interpharma, une plate-forme qui renforce notre engagement pour des solutions innovantes dans le syst\u00e8me de sant\u00e9. Tout en continuant d\u2019\u00e9tendre nos activit\u00e9s en Suisse, en particulier dans le domaine des traitements cardio-vasculaires et oncologiques, nous nous r\u00e9jouissons d\u2019avance de la coop\u00e9ration avec d\u2019autres entreprises leaders pour am\u00e9liorer les r\u00e9sultats des traitements pour les patients, faire avancer la recherche et contribuer \u00e0 l\u2019\u00e9cosyst\u00e8me de sant\u00e9 florissant du pays\u00bb.<\/p>\n\n\n\n<p>\u00abNous sommes tr\u00e8s heureux d\u2019accueillir Daiichi Sankyo, un leader dans le domaine de la recherche pharmaceutique, en tant que nouveau membre\u00bb, dit Ren\u00e9 Buholzer, directeur d\u2019Interpharma. \u00abL\u2019adh\u00e9sion de Daiichi Sankyo renforce encore la position d\u2019Interpharma en tant qu\u2019organisation fa\u00eeti\u00e8re des entreprises pharmaceutiques pratiquant la recherche en Suisse. Les membres d\u2019Interpharma repr\u00e9sentent ainsi nettement plus de 90% de parts du march\u00e9 des m\u00e9dicaments prot\u00e9g\u00e9s par un brevet et rembours\u00e9s par les caisses-maladie\u00bb.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-nouveaux-elus-au-comite-directeur\"><strong>Nouveaux \u00e9lus au comit\u00e9 directeur<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>L\u2019assembl\u00e9e g\u00e9n\u00e9rale a nouvellement \u00e9lu au comit\u00e9 directeur: <strong><\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>D<sup>re<\/sup> Iris Zemzoum, President Region Europe, Novartis<\/li>\n\n\n\n<li>D<sup>r<\/sup> David Traub, President Innovative Medicines Switzerland Novartis<\/li>\n\n\n\n<li>Florian Saur, Country President, AstraZeneca Switzerland<\/li>\n\n\n\n<li>Linn Mandahl Vice President Europe South, AbbVie<\/li>\n\n\n\n<li>D<sup>re<\/sup> Annette Luther, Head External Affairs Switzerland, Roche<\/li>\n<\/ul>\n\n\n\n<p>Interpharma se r\u00e9jouit de pouvoir compter sur l\u2019engagement et les comp\u00e9tences de ces personnalit\u00e9s pour le bien de la place pharmaceutique suisse et de ses patient-e-s.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-la-suisse-ne-doit-avoir-de-cesse-de-s-ameliorer\"><strong>La Suisse ne doit avoir de cesse de s\u2019am\u00e9liorer<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>La Suisse et ses entreprises pharmaceutiques sont une belle histoire \u00e0 succ\u00e8s: des conditions cadres attrayantes pour la recherche et le d\u00e9veloppement aident les entreprises pharmaceutiques \u00e0 faire des investissements consid\u00e9rables, ce qui permet des innovations qui b\u00e9n\u00e9ficient \u00e0 la population ainsi qu\u2019\u00e0 la place \u00e9conomique. La branche pharmaceutique g\u00e9n\u00e8re quelque 6% de la valeur ajout\u00e9e brute de la Suisse, pr\u00e8s de 10% compte tenu des effets indirects, ce qui place la Suisse dans le peloton de t\u00eate en comparaison internationale. Les entreprises suisses ont d\u00e9velopp\u00e9 des m\u00e9dicaments et vaccins pionniers qui am\u00e9liorent la prise en charge sanitaire dans le monde entier. C\u2019est ainsi que la mortalit\u00e9 par cancer a recul\u00e9 de 24% depuis 1995. La branche emploie quelque 282&nbsp;000 personnes et contribue \u00e0 hauteur de pr\u00e8s de 50% aux exportations de la Suisse. Ces dix derni\u00e8res ann\u00e9es, la performance \u00e9conomique r\u00e9elle de l\u2019industrie pharmaceutique a tripl\u00e9, apportant plus de 40% de la croissance \u00e9conomique suisse. Mais cet environnement favorable ne va pas de soi. Un coup d\u2019\u0153il aux investissements pr\u00e9vus montre que, dans les prochaines ann\u00e9es, de nombreuses entreprises n\u2019investiront plus en Suisse. Ce dont nous avons besoin: pr\u00e9visibilit\u00e9 et s\u00e9curit\u00e9 juridique pour les investissements \u00e0 long terme, acc\u00e8s rapide des patient-e-s aux nouveaux m\u00e9dicaments innovants et relations stables et encadr\u00e9es avec les principaux march\u00e9s.<\/p>\n\n\n\n<p>Vous trouverez le rapport annuel 2024 d\u2019Interpharma \u00e0 l\u2019adresse: <a href=\"file:\/\/\/https:\/www.interpharma.ch\/shop\/?pub_id=24644\">www.interpharma.ch<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c0 partir d\u2019aujourd\u2019hui, Interpharma, l\u2019association des entreprises pharmaceutiques suisses pratiquant la recherche, compte un nouveau membre en pointe dans le domaine de la recherche: Daiichi Sankyo. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale annuelle, le comit\u00e9 directeur a \u00e9t\u00e9 compl\u00e9t\u00e9 par des personnalit\u00e9s responsables \u00e0 l\u2019\u00e9chelon suisse et europ\u00e9en. En outre, le rapport annuel 2024 a \u00e9t\u00e9 pr\u00e9sent\u00e9. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3449,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[130,122],"class_list":["post-12144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-pharmastandort-2030-fr","tag-communique-de-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma\" \/>\n<meta property=\"og:description\" content=\"\u00c0 partir d\u2019aujourd\u2019hui, Interpharma, l\u2019association des entreprises pharmaceutiques suisses pratiquant la recherche, compte un nouveau membre en pointe dans le domaine de la recherche: Daiichi Sankyo. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale annuelle, le comit\u00e9 directeur a \u00e9t\u00e9 compl\u00e9t\u00e9 par des personnalit\u00e9s responsables \u00e0 l\u2019\u00e9chelon suisse et europ\u00e9en. En outre, le rapport annuel 2024 a \u00e9t\u00e9 pr\u00e9sent\u00e9. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-01T07:46:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:29:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"357\" \/>\n\t<meta property=\"og:image:height\" content=\"458\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma\",\"datePublished\":\"2025-04-01T07:46:23+00:00\",\"dateModified\":\"2026-03-03T09:29:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/\"},\"wordCount\":722,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg\",\"keywords\":[\"Pharmastandort 2030\",\"Communiqu\u00e9 de presse\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/\",\"name\":\"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg\",\"datePublished\":\"2025-04-01T07:46:23+00:00\",\"dateModified\":\"2026-03-03T09:29:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg\",\"width\":357,\"height\":458},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma","og_description":"\u00c0 partir d\u2019aujourd\u2019hui, Interpharma, l\u2019association des entreprises pharmaceutiques suisses pratiquant la recherche, compte un nouveau membre en pointe dans le domaine de la recherche: Daiichi Sankyo. Lors de l\u2019assembl\u00e9e g\u00e9n\u00e9rale annuelle, le comit\u00e9 directeur a \u00e9t\u00e9 compl\u00e9t\u00e9 par des personnalit\u00e9s responsables \u00e0 l\u2019\u00e9chelon suisse et europ\u00e9en. En outre, le rapport annuel 2024 a \u00e9t\u00e9 pr\u00e9sent\u00e9. [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/","og_site_name":"Interpharma","article_published_time":"2025-04-01T07:46:23+00:00","article_modified_time":"2026-03-03T09:29:38+00:00","og_image":[{"width":357,"height":458,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma","datePublished":"2025-04-01T07:46:23+00:00","dateModified":"2026-03-03T09:29:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/"},"wordCount":722,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg","keywords":["Pharmastandort 2030","Communiqu\u00e9 de presse"],"inLanguage":"fr-FR","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/","name":"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg","datePublished":"2025-04-01T07:46:23+00:00","dateModified":"2026-03-03T09:29:38+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/04\/Ausschnitt-Jahresbericht-2024.jpg","width":357,"height":458},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Daiichi Sankyo devient membre d\u2019Interpharma"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12144"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12144\/revisions"}],"predecessor-version":[{"id":12145,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12144\/revisions\/12145"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/3449"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12144"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}